Trendlines Group Ltd. engages in the investment and development of medical and agricultural technology companies. The company invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Group’ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.
최신 재무제표(Form-10K)에 따르면, The Trendlines Group Ltd.의 총 자산은 $85이며, 순이익입니다.
TRNGF의 주요 재무 비율은 무엇인가요?
The Trendlines Group Ltd.의 유동비율은 12.14이고, 순이익률은 0, 주당 매출은 $0입니다.
The Trendlines Group Ltd.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
The Trendlines Group Ltd. 주요 수익원은 Innovative Agrifood Tech and Medical Device이며, 최신 수익 발표에서 수익은 -661,522입니다. 지역별로는 Israel이 The Trendlines Group Ltd.의 주요 시장이며, 수익은 -661,522입니다.
The Trendlines Group Ltd.은 수익성이 있나요?
예, 최신 재무제표에 따르면 The Trendlines Group Ltd.의 순이익은 $1입니다.